Pivotal Therapeutics Inc.
PVTTF
Market Cap$173.82K
Close$
Share Statistics
| Market cap | $173,820.00 |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.0 |
| Outstanding Shares | 96,566,669 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Pivotal Therapeutics, Inc.
CEO: Rachelle MacSweeney Pivotal Therapeutics, Inc. is a pharmaceutical company, which engages in the optimization of Omega-3 therapy for cardiovascular disease and overall health. Its products include Benefishial, Omazen, and Vascazen. The company was founded b...